Orion Biologics
Scope
Date
~
-
Food & Beverage
Orion’s Turtle Chips launches in Vietnam, India
South Korea's confectionary giant Orion Corp. is launching its popular snack "Kkobuk Chip" in Vietnam and India. Orion announced on Monday that it h...
Apr 17, 2023 (Gmt+09:00)
-
Korean food
S. Korea's Orion sees brisk sales growth in Vietnam, Russia
South Korea's confectionary giant Orion Corp. has seen brisk sales growth this year, pushing out rival CJ CheilJedang Corp. to solidify its dominanc...
Apr 06, 2023 (Gmt+09:00)
-
Bio & Pharma
Lotte Biologics, Excellgene to collaborate on CDO biz
Lotte Biologics, South Korea's biopharmaceutical contract development and manufacturing organization (CDMO) company, announced on Sunday that it has...
Apr 03, 2023 (Gmt+09:00)
-
Bio & Pharma
Samsung Biologics to invest $1.5 bn for 5th CDMO factory
Samsung Biologics Co. is slated to inject 2 trillion won ($1.5 billion) to build its fifth plant in South Korea. It will be a fast follow-up investm...
Mar 16, 2023 (Gmt+09:00)
-
Bio & Pharma
S.Korea's Prestige Biologics attracts $59 mn overseas investment
Prestige Biologics Co., a South Korean biopharmaceutical contract development and manufacturing organization (CDMO) company, announced on Tuesday th...
Mar 15, 2023 (Gmt+09:00)
-
Bio & Pharma
Samsung Biologics bags $183 million CMO order from Pfizer
Samsung Biologics Co., the world’s No. 1 contract drug maker in terms of production capacity, has won a $182.7 million contract manufacturing ...
Mar 02, 2023 (Gmt+09:00)
-
Food & Beverage
Snack maker Orion to pursue M&As, expand Vietnam facility
South Korea’s confectionery and snack maker Orion Corp. reported its largest-ever earnings last year, driven by strong sales in emerging marke...
Feb 08, 2023 (Gmt+09:00)
-
Earnings
Samsung Biologics’ profit near doubles on strong orders
Samsung Biologics Co., the world’s top contract drugmaker, said its profit almost doubled last year thanks to more orders as its sales surged ...
Jan 29, 2023 (Gmt+09:00)
-
Chief Executives
Samsung Biologics CEO focuses on global business
John Rim, chief executive of Samsung BioLogics will directly lead his company's global sales operations for biopharmaceuticals through contract deve...
Jan 26, 2023 (Gmt+09:00)
-
Bio & Pharma
Lotte to invest more in US bio biz, spend $3 bn in Korea
SAN FRANCISCO -- South Korea’s Lotte Biologics Co. is considering investing more in the US bio industry and spending $3 billion in new factori...
Jan 11, 2023 (Gmt+09:00)
-
Carbon neutrality
Samsung Biologics receives Terra Carta Seal
Samsung Biologics Co., the world’s largest contract drugmaker, said on Wednesday it was awarded the Sustainable Markets Initiative’s Ter...
Jan 11, 2023 (Gmt+09:00)
-
Mergers & Acquisitions
Hansol Chemical to enter bio industry with BiOCS acquisition
Hansol Chemical Co., a unit of South Korea’s paper-focused conglomerate Hansol Group, is expanding its business scope to biomaterials by acqui...
Dec 27, 2022 (Gmt+09:00)
-
Food & Beverage
Korean confectionery and snack co. Orion enjoys brisk sales in Vietnam
South Korea’s confectionery and snack maker Orion Corp. is enjoying rapid growth in Vietnam, thanks to brisk sales of the Choco-Pie, a chocola...
Dec 22, 2022 (Gmt+09:00)
-
Bio & Pharma
Orion to enter dental disease treatment sector
Orion Corp., the Korean company, best known for its signature product choco pie, is entering drug development. Instead of indirectly running a joint...
Nov 30, 2022 (Gmt+09:00)
-
Bio & Pharma
Samsung Biologics in CDO deal talks with global pharma firm
FRANKFURT – Samsung Biologics Co., the world’s largest contract drugmaker, is in talks to develop medicines for a global pharmaceutical ...
Nov 07, 2022 (Gmt+09:00)
-
Bio & Pharma
Korea's Samsung Biologics signs $296 mn CMO deal with GSK
South Korea’s Samsung Biologics Co. has signed a $296.1 million deal to supply biopharmaceutical products to UK-based multinational pharma gia...
Oct 21, 2022 (Gmt+09:00)
-
Bio & Pharma
Samsung Biologics opens the world's largest CDMO factory
South Korea’s Samsung Biologics Co.’s new biopharmaceuticals plant launched operations on Tuesday, a move expected to widen the gap betw...
Oct 11, 2022 (Gmt+09:00)
-
Bio & Pharma
Samsung Biologics, Samsung C&T extends investment in US biotech firms
The Life Science Fund, jointly launched by Samsung Biologics and Samsung C&T Corp., announced Wednesday it invested $15 million in US biotech fi...
Aug 17, 2022 (Gmt+09:00)
-
Bio & Pharma
Samsung Biologics to double CDMO capacity with new plants worth $5.3 bn
Samsung Biologics Co., the world’s largest contract drugmaker, plans to double its manufacturing capacity by building four additional plants w...
Jul 18, 2022 (Gmt+09:00)
-
Bio & Pharma
Orion enters China’s vaccine market with tuberculosis plant in Jining
Orion Holdings Corp., one of South Korea’s largest confectionery companies, said on Wednesday it will build a vaccine plant in China by 2024 t...
Jul 13, 2022 (Gmt+09:00)
language -
Bio & Pharma
Celltrion, Samsung Biologics eye record-high annual sales
South Korea’s two major biopharmaceutical companies, Celltrion Inc. and Samsung Biologics Co., are respectively expecting more than 2 trillion...
Jul 08, 2022 (Gmt+09:00)
-
Bio & Pharma
Samsung Biologics signs $81 mn CMO deal with Novartis
South Korea’s Samsung Biologics Co. has inked an $81 million contract manufacturing deal with Novartis, the world’s fifth-largest pharma...
Jun 07, 2022 (Gmt+09:00)
language -
Mergers & Acquisitions
Lotte to buy BMS' biologics plant in Syracuse for $160 mn
South Korea's Lotte Group has agreed to buy Bristol Myers Squibb's (BMS) biologics plant in Syracuse in the state of New York for $160 million, the ...
May 13, 2022 (Gmt+09:00)
-
Bio & Pharma
Kolon Life inks technology transfer deal with Juniper Biologics
South Korea’s pharmaceutical company Kolon Life Science Inc. signed a technology export deal worth up to 723.4 billion won ($589.1 million) wi...
Apr 13, 2022 (Gmt+09:00)
-
Rights offerings
Samsung Biologics to raise $2.6 bn in rights issue
Samsung Biologics Co., a global contract development and manufacturing organization (CDMO) and a biotech division under the Samsung Group, is set ...
Apr 12, 2022 (Gmt+09:00)
-
COVID-19
Korea approves export of Samsung Biologics-made Moderna vaccine
South Korea approved exports of Moderna Inc.’s COVID-19 vaccine produced by Samsung Biologics Co. in a move that will help the country’s...
Dec 14, 2021 (Gmt+09:00)
language -
Pharmaceuticals
Samsung Biologics wins another Eli Lilly COVID treatment order
Samsung Biologics Co., a global contract development and manufacturing organization (CDMO), has stepped up its partnerships with global big pharmas ...
Nov 19, 2021 (Gmt+09:00)
-
COVID-19
Samsung Biologics-made Moderna vaccine available to Koreans this week
Moderna Inc.’s COVID-19 vaccine first produced by Samsung Biologics Co. under a contract manufacturing organization (CMO) service will be avai...
Oct 27, 2021 (Gmt+09:00)
language -
COVID-19
Samsung Biologics gears up to produce mRNA drug substance
South Korea’s Samsung Biologics Co. is gearing up for the drug substance (DS) sector of the messenger ribonucleic acid (mRNA)-based COVID-19 v...
Sep 01, 2021 (Gmt+09:00)
language -
COVID-19
Korean govt to spend $1.9 billion to become world’s leading vaccine maker
The South Korean government will invest 2.2 trillion won ($1.9 billion) by 2025 to become a top five vaccine producer in the world. President Moon J...
Aug 05, 2021 (Gmt+09:00)
Latest News
- 1 Affinity-backed SSG.COM offers first voluntary redundancy
- 2 Lotte to cut basic chemicals in portfolios for profitability
- 3 Young rich Koreans: Financially literate, self-directing
- 4 LG Elec logs record Q2 profit on home appliances, car parts
- 5 Samsung's Q2 profit soars on AI chips; 2024 outlook bright